Figure 2
Immunohistochemistry of hRad9, cyclin D1 and chk1 in breast carcinoma.
Positive expression of hRad9, chk1 and cyclin D1 in chemoresistant breast carcinoma (a) comparing with that of negative expression in chemosensitive carcinoma (b).
Figure 2 | Scientific Reports
